Ticker: KALV

Company: KalVista Pharmaceuticals, Inc.

Person: Christopher Yea, officer

Transaction date: Nov. 20, 2025

Reporting date: Nov. 21, 2025

Average share price: 0.0043

Bought 87390.0 shares for 375.78